38. スティーヴンス・ジョンソン症候群 ［臨床試験数：11，薬物数：19（DrugBank：8），標的遺伝子数：14，標的パスウェイ数：98］
Searched query = "Stevens-Johnson syndrome", "SJS", "Mucocutaneous ocular syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||JPRN-jRCTs061180044||01/06/2017||12/03/2019||Multicenter Open-trial of Steroid pulse therapy for SJS/TEN||Multicenter Open-trial of Steroid pulse therapy for SJS/TEN - MOSST Study||Stevens-Johnson syndrome and Toxic epidermal necrolysis||1. infusion of methylprednisolone at 500~1000 mg/d|
(0.9% N/S in 3 hour) for 3 consecutive days.
2. Oral predonisolone (0.5 mg/kg/d) was initiated on the
day following the last dose of methylprednisolone, and
prednisolone was subsequently tapered within 2 weeks.
If the ocular involvement score is more than 2, dose of
oral predonisolone (1 mg/kg/d) is recommended.
|Morita Eishin||NULL||Not Recruiting||>= 20age old||<= 90age old||Both||20||Phase 2||Taiwan;Germany;Japan|